H35 HypOxystation used in heart regeneration project

Dr Vaibhao Janbandhu is a Postdoctoral Research Scientist at the Victor Chang Cardiac Research Institute (VCCRI) in Sydney. He has been in contact with Don Whitley Scientific to explain how his lab’s work has benefited from the use of a Whitley H35 HypOxystation. Vaibhao uses the HypOxystation to isolate, culture and characterise adult cardiac stem cells (CSCs).

Dr Janbandhu had already been using a H35 that was set up at the institute for almost three years before he got his own unit installed last year. Specifically, his project is to find new ways to stimulate heart regeneration during ageing and after heart attack. For this he needs a way to isolate, culture and characterise adult CSCs. In Vaibhao’s words the H35 Hypoxystation seems well suited for this application: “the DWS HypOxystation provides a highly stabilised environment in which levels of oxygen, carbon dioxide, temperature and humidity are precisely controlled and it will be an integral part of the project to advance the project aims”.

Read more: H35 HypOxystation used in heart regeneration project

Treating advanced cancers by implanting polymer-entrapped palladium nano particles within a tumor

Selective activation of a drug precursor in an orthogonal manner can reduce the adverse systemic effects of the therapy. In a 2015 paper published in Scientific Reports (Vol 5, 9329), HypOxystation users Weiss et al. describe a therapeutic strategy to treat advanced cancers by implanting polymer-entrapped palladium nanoparticles within a tumor in order to continuously induce the activation of propargylated Pro-FUdR to FUdr, a DNA synthesis-disrupting antimetabolite, which is administered enterally. In their paper “Palladium-mediated dealkylation of N-propargyl-floxuridine as a bioorthogonal oxygen-independent prodrug strategy”, they describe the balancing act necessary to design and synthesize a compound that is inactive but resistant to metabolic degradation outside of the tumor, reducing its cytotoxicity for the patient 6,250-fold, which can then be chemically activated by palladium, aided by the specific micro­environment present inside the tumor.

Read more: Treating advanced cancers by implanting polymer-entrapped palladium nano particles within a tumor

Examining the influence of hypoxia and normoxia on the expression of the H2S-producting enzymes CBS, CSE and MPS

Approximately 80% of renal cell carcinomas are of the clear cell subtype ccRCC, and common characteristics of this cancer include inactivation of the Von Hippel-Lindau tumor suppressor, leading to dysregulation of HIF-1 and 2α transcription factors and ultimately a pseudohypoxic tumor signature. Altered metabolism and upregulation of angiogenic factors result, and while therapies addressing individual such shifts are employed, an approach that targets the fundamental basis of the dysregulated survival and proliferation of ccRCC cells would increase effectivity while reducing systemic side effects.

HypOxystation users Sonke et al. in Canada examined the involvement of hydrogen sulfide H2S in angiogenesis, cytoprotection and metabolism in VHL-deficient ccRCC, where endogenous H2S accumulates as mitochondrial oxidation ceases under hypoxia and pseudo-hypoxia (“Inhibition of endogenous hydrogen sulfide production in clear-cell renal cell carcinoma cell lines and xenografts restricts their growth, survival and angiogenic potential; Nitric Oxide. 2015 Sep 15;49:26-39 “). The Sonke lab used the H85 HypOxystation by Don Whitley Scientific to examine the influence of hypoxia (1%) and normoxia on the expression of the H2S-producing enzymes CBS, CSE and MPS; cell viability under treatment with hydroxylamine HA, a CBS/CSE inhibitor, was also compared at normoxia and at hypoxia in the HypOxystation. The closed hypoxic environment created in the HypOxystation provides stable parameters favoring in vivo physiology of cancer cells. Using an avian chorioallantoic membrane xenograft system, they examined the inhibitory effects of H2S on neovascularization.

Read more: Examining the influence of hypoxia and normoxia on the expression of the H2S-producting enzymes...

Interaction of DNA damage kinase ATM with the ATM interactor ATMIN at hypoxia

DNA repair pathways protecting against genomic instability are significantly repressed under the hypoxic conditions typical of many solid tumors. HypOxystation users Leszczynska et al. describe the interaction of DNA damage kinase ATM with the ATM interactor ATMIN at hypoxia as well as the downstream consequences for DNA repair (“Mechanisms and consequences of ATMIN  repression in hypoxic conditions: roles for p53 and HIF-1” , Scientific Reports 6:21698; 2016).

ATM activation is induced at severe hypoxia as a result of replication stress, and was thought to be dependent on the ATM interactor ATMIN, especially in the absence of DNA damage. Using ATMIN siRNA, ATM inhibitors, and knock-out cell lines, the authors were able to establish that ATMIN is not required for the activation of ATM in response to hypoxia-induced replication stress, and that ATMIN is repressed at hypoxia, an effect mediated by both p53 and HIF-1. The cells were exposed to varying degrees of hypoxia, from mild (2%) down to extreme (0.1%) in an H35 HypOxystation by Don Whitley Scientific. The closed cell culture environment created in the Don Whitley Scientific HypOxystation mimics physiological conditions with regard to oxygen, CO2, temperature, and humidity and enables cancer researchers to obtain a clearer picture of in vivo processes. qPCR analysis of cells in response to hypoxia and exposure to inhibitors of proteasomal degradation indicate that the repressive effect of hypoxia is due to inhibition of translation as opposed to transcription or altered stability of ATMIN.

Read more: Interaction of DNA damage kinase ATM with the ATM interactor ATMIN at hypoxia